✦ LIBER ✦
Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non–HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein
✍ Scribed by Michael H. Davidson; Nicola Abate; Christie M. Ballantyne; Alberico L. Catapano; Xia Xu; Jianxin Lin; Elizabeth Rosenberg; Andrew M. Tershakovec
- Book ID
- 119287659
- Publisher
- Elsevier
- Year
- 2008
- Tongue
- English
- Weight
- 263 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1933-2874
No coin nor oath required. For personal study only.